The present invention relates to intracranial electrodes and methods for implanting and using intracranial electrodes. These electrodes and methods are particularly well suited for neurostimulation systems and may also be used in electroencephalography and other recording systems, e.g., evoked potential recordings.
A wide variety of mental and physical processes are known to be controlled or influenced by neural activity in the central and peripheral nervous systems. For example, the neural functions in some areas of the brain (e.g., the sensory or motor cortices) are organized according to physical or cognitive functions. Several other areas of the brain also appear to have distinct functions in most individuals. In the majority of people, for example, the areas of the occipital lobes relate to vision, the regions of the left inferior frontal lobes relate to language, and the regions of the cerebral cortex appear to be involved with conscious awareness, memory, and intellect. Because of the location-specific functional organization of the brain, in which neurons at discrete locations are statistically likely to control particular mental or physical functions in normal individuals, stimulating neurons at selected locations of the central nervous system can be used to effectuate changes in cognitive and/or motor functions throughout the body.
In several existing applications, neural functions are treated or augmented by electrical or magnetic stimulation powered by a neural stimulator that has a plurality of therapy electrodes and a pulse system coupled to the therapy electrodes. The therapy electrodes can be implanted into the patient at a target site for stimulating the desired portions of the brain. For example, one existing technique for masking pain in a patient is to apply an electrical stimulus to a target stimulation site of the brain. In other applications, transcranial magnetic stimulation (TMS) of an appropriate target site in the brain has shown promise for treating damage to and disease and disorders of the brain, including depression and, possibly, obsessive-compulsive behavior.
The brain can be stimulated in several known fashions. One type of treatment is referred to as transcranial electrical stimulation (TES), which involves placing an electrode on the exterior of the patient's scalp and delivering an electrical current to the brain through the scalp and the skull. TES, however, is not widely used because the delivery of the electrical stimulation through the scalp and the skull causes patients a great amount of pain and the electrical field is difficult to direct or focus accurately.
Another type of treatment is the transcranial magnetic stimulation (TMS) identified above. TMS, involves using a high-powered magnetic field adjacent the exterior of the scalp over an area of the cortex. TMS does not cause the painful side effects of TES. Unfortunately, TMS is not presently effective for treating many patients because the existing delivery systems are not practical for applying stimulation over an adequate period of time. TMS systems, for example, are relatively complex and require stimulation treatments to be performed by a healthcare professional in a hospital or physician's office. The efficacy of TMS in longer-term therapies may be limited because it is difficult to (a) accurately localize the region of stimulation in a reproducible manner, (b) hold the device in the correct position over the cranium for the requisite period, and (c) provide stimulation for extended periods of time.
Another device for stimulating a region of the brain is disclosed by King in U.S. Pat. No. 5,713,922, the entirety of which is incorporated herein by reference. King discloses a device for cortical surface stimulation having electrodes mounted on a paddle that is implanted under the skull of the patient. These electrodes are placed in contact with the surface of the cortex to create “paresthesia,” which is a vibrating or buzzing sensation. Implanting the paddle typically requires removal of a relatively large (e.g., thumbnail-sized or larger) window in the skull via a full craniotomy. Craniotomies are performed under a general anesthetic and subject the patient to increased chances of infection.
A physician may employ electroencephalography (EEG) to monitor neural functions of a patient. Sometimes this is done alone, e.g., in diagnosing epileptic conditions, though it may also be used in conjunction with neurostimulation. Most commonly, electroencephalography involves monitoring electrical activity of the brain, manifested as potential differences at the scalp surfaces, using electrodes placed on the scalp. The electrodes are typically coupled to an electroencephalograph to generate an electroencephalogram. Diagnosis of some neurological diseases and disorders, e.g., epilepsy, may best be conducted by monitoring neural function over an extended period of time. For this reason, ambulatory electroencephalography (AEEG) monitoring is becoming more popular. In AEEG applications, disc electrodes are applied to the patient's scalp. The scalp with the attached electrodes may be wrapped in gauze and the lead wires attached to the electrodes may be taped to the patient's scalp to minimize the chance of displacement.
EEG conducted with scalp-positioned electrodes requires amplification of the signals detected by the electrodes. In some circumstances, it can be difficult to pinpoint the origin of a particular signal because of the signal dissipation attributable to the scalp and the skull. For more precise determinations, EEG may be conducted using “deep brain” electrodes. Such electrodes extend through the patient's scalp and skull to a target location within the patient's brain. Typically, these deep brain electrodes comprise lengths of relatively thin wire that are advanced through a bore through the patient's skull to the desired location. If the electrodes are to be monitored over an extended period of time, the electrodes typically are allowed to extend out of the patient's skull and scalp and are coupled to the electroencephalograph using leads clipped or otherwise attached to the electrodes outside the scalp. To avoid shifting of the electrodes over time, the electrodes typically are taped down or held in place with a biocompatible cementitious material. The patient's head typically must be wrapped in gauze to protect the exposed electrodes and the associated leads, and the patient is uncomfortable during the procedure. This may be suitable for limited testing purposes-deep brain encephalography typically is limited to tests conducted in hospital settings over a limited period of time, usually no more than a few days—but could be problematic for longer-term monitoring, particularly in nonclinical settings.
Screws have been used to attach plates or the like to patients'skulls.
A. Overview
Various embodiments of the present invention provide intracranial electrodes and methods for implanting and using intracranial electrodes. It will be appreciated that several of the details set forth below are provided to describe the following embodiments in a manner sufficient to enable a person skilled in the art to make and use the disclosed embodiments. Several of the details and advantages described below, however, may not be necessary to practice certain embodiments of the invention. Additionally, the invention can also include additional embodiments that are not described in detail with respect to
One embodiment of the invention provides an intracranial electrode that includes a shaft, a head, and threads. The shaft includes a distal contact surface adapted to electrically contact a surface of a patient's brain. The head is associated with the shaft and is sized to be positioned subcutaneously adjacent the patient's skull. This can ameliorate the difficulties associated with electrodes that protrude through the patient's scalp, including irritation of the skin and discomfort. The threads are carried by at least one of the head and the shaft and may be adapted to fix the electrode with respect to the patient's skull. This intracranial electrode has an adjustable length adapted to change a contact force of the distal contact surface against the surface of the brain by adjusting the length of the electrode. In one adaptation of this embodiment, the intracranial electrode includes an adjustment means that is adapted to adjust the length of the electrode.
Another embodiment of the invention provides an intracranial electrode that includes an electrically conductive member, a dielectric member, and an anchor. The electrically conductive member has a blunt contact surface and the dielectric member has an interior in which the electrically conductive member is received. The anchor may be carried by the electrically conductive member or the dielectric member. The anchor is adapted to anchor at least one of the electrically conductive member and the dielectric member with respect to a patient's skull adjacent a brain surface such that the contact surface of the electrically conductive member is in electrical contact with the brain surface and the dielectric member electrically insulates the skull from the electrically conductive member.
Another embodiment of the invention provides a neurostimulator system. This neurostimulator system includes an intracranial electrode, a lead, and a pulse system. The intracranial electrode may take the form of one of the preceding embodiments. In one particular implementation, the intracranial electrode includes a shaft including a distal contact surface adapted to electrically contact a surface of a patient's brain; a head associated with the shaft, with the head being sized to be positioned subcutaneously adjacent the patient's skull; and threads carried by at least one of the head and the shaft, with the threads being adapted to fix the electrode with respect to the patient's skull. The lead is adapted to be subcutaneously implanted beneath the patient's scalp. The lead has a first portion, which is adapted to be electrically coupled to the contact surface, and an electrically insulated implantable length. The pulse system is adapted to be implanted in the patient's body at a location spaced from the electrode. The pulse system is operatively coupled to the electrode via the lead to deliver an electrical stimulus to the brain via the electrode. If so desired, an array of such intracranial electrodes may be employed and the pulse system may be adapted to generate an electrical potential between the electrodes in the array.
A method of implanting an intracranial electrode in accordance with another embodiment of the invention involves advancing a threaded electrode through a patient's skull until a contact surface of the electrode is in atraumatic contact with a surface of the patient's brain. The threaded electrode is electrically coupled to a lead. A head of the electrode and the length of the lead are covered with the patient's scalp, thereby enclosing the electrode. An electrical stimulus is delivered to the patient's brain via the electrode. This electrical stimulus may be generated by a pulse system electrically coupled to the electrode by the lead. In one adaptation of this embodiment, the method may also include adjusting a length of the electrode, e.g., to adjust the force of the contact surface of the electrode against the surface of the brain.
For ease of understanding, the following discussion is subdivided into three areas of emphasis. The first section discusses certain intracranial electrodes; the second section relates to select embodiments of neurostimulation systems; and the third section outlines methods in accordance with other embodiments of the invention.
B. Intracranial Electrodes
In one embodiment, the intracranial electrode 100 is adapted to be electrically connected to a pulse system (1050 in
The head 102 of the electrode 100 is adapted to be implanted subcutaneously beneath the patient's scalp 30 (shown schematically in
The dimensions of the electrode 100 can be varied to meet various design objectives. In one embodiment, however, the electrode 100 is longer than the thickness of the patient's skull. More specifically, the head 102 is adapted to be seated at an extracranial subcutaneous site while the threaded shaft 110 is only slightly longer than the skull thickness at the intended treatment site. Lengths on the order of 4-50 mm, for example, may be appropriate in certain applications. The diameter of the head 102 and the threaded shaft 110 may also be varied. For most applications, shafts 110 having diameters (typically excluding the width of the threads 112) of no greater than 4 mm will suffice. Shaft diameters of about 14 mm are likely, with diameters of 1.5-2.5 mm being well suited for most applications.
The connection of the electrode 150 to the lead 160 in
In one embodiment, the cap 162 is sized to be subcutaneously implanted beneath the patient's scalp 30. In the illustrated embodiment, the head 152 and the cap 162 both extend outwardly beyond the outer cortex 12 of the patient's skull 10. In another embodiment (not shown) some or all of the length of the head 152 and/or the cap 162 may be countersunk into a recess formed through the outer cortex 12 and/or an outer portion of the cancellous 18. This can improve patient comfort, which can be useful if the intracranial electrode 150 is intended to be implanted permanently or for an extended period of time.
When implanted in a skull 10 as shown in
In one particular embodiment, the dielectric layer 280 comprises an electrically insulative ceramic material. In another embodiment, the dielectric layer 280 comprises an electrically insulative plastic or other biocompatible polymer that has sufficient structural integrity to adequately anchor the electrode 250 to the skull 10 for the duration of its intended use. If so desired, the dielectric layer 280 may be porous or textured to promote osseointegration of long-term implants. For shorter-term applications, the dielectric layer 280 may be formed of or covered with a material that will limit osseointegration.
In each of the preceding embodiments, the intracranial electrode 100, 150, 200, or 250 has a fixed length. In the embodiment shown in
The intracranial electrode 300 of
The head 320 of the electrode 300 comprises a body 322 and a tubular length 324 that extends from the body 322. The body 322 may be adapted to be rotated by hand or by an installation tool. In one embodiment the body 322 is generally hexagonal to facilitate rotation with an appropriately sized wrench. In the particular embodiment shown in
The head 320 includes an internally threaded bore 326 that extends through the thickness of the body 322 and the tubular length 324. The bore 326 has threads sized to mate with the external threads on the shaft 310. If so desired, a biocompatible sealant (e.g., a length of polytetrafluoroethylene tape) may be provided between the threads of the bore 326 and the threads of the shaft 310 to limit passage of fluids or infectious agents through the bore 326.
Rotation of the shaft 310 with respect to the head 320 will, therefore, selectively advance or retract the shaft 310 with respect to the head 320. This will, in turn, increase or decrease, respectively, the distance between the lower face 323 of the head body 322 and the contact surface 315 of the shaft 310. As suggested in
If so desired, the torque driver 340 may include graduations 342 to inform the physician how far the shaft 310 has been advanced with respect to the head 320. As noted below, in certain methods of the invention, the thickness of the skull at the particular treatment site may be gauged before the electrode 300 is implanted. Using this information and the graduations 342 on the torque driver 340, the physician can fairly reliably select an appropriate length for the electrode 300 to meet the conditions present at that particular site.
In the embodiment shown in
In another embodiment, the head 320 is formed of a dielectric material, such as a dielectric ceramic or plastic. This may necessitate a different connection between the lead 120 and the shaft 310, such as by electrically contacting the lead 120 to the proximal end 312 of the shaft 310. Employing a dielectric head 320 can help electrically insulate the skull 10 from the electrodes 300, improving signal quality and reducing interference between the various electrodes 300 in an array, as noted above.
The intracranial electrode 350 of this embodiment also includes a head 370 having an internally threaded bore 376 extending through its thickness. The threads of the bore 376 are adapted to mate with the threads of the first threaded portion 360a. By rotating the shaft 360 with respect to the head 370 (e.g., with a screwdriver 340), the distance between the head 370 and the contact surface 365 can be adjusted in much the same manner described above in connection with
The head 320 of the electrode 300 in
In the embodiment of
In the preceding embodiments, some or a majority of the head of the electrode extends outwardly beyond the outer surface of the skull 10. In the particular implementation shown in
The head 420 includes a base 430 and an actuator 422. The base 430 includes an externally threaded body 432 and a tubular length 434 that extends from the body 432. A portion of the tubular length 434 carries external threads 436. The tubular length 434 may also include one or more locking tabs 440, each of which includes an actuating surface 442.
The actuator 422 has an internally threaded bore 424 that is adapted to matingly engage the threads 436 on the base 430. Rotating the actuator 422 with respect to the base 430 in a first direction will advance the actuator 422 toward the actuating surface 442 of each of the tabs 440. The actuator 422 may urge against the actuating surfaces 442, pushing the tabs 440 inwardly into engagement with the shaft 410. This will help lock the shaft 410 in place with respect to the base 430. Rotating the actuator 422 in the opposite direction will allow the tabs 440 to resiliently return toward a rest position wherein they do not brake movement of the shaft 410. The force with which the shaft 410 engages the dura mater 20 (not shown) then can be adjusted to a desired level by moving the shaft 410 with respect to the base 430. When the shaft 410 is in the desired position, the actuator 422 may be moved into engagement with the tabs 440 to hold the shaft 410 in the desired position.
The contact surface 455 of the shaft 452 is pushed against the surface of the dura mater 20 with a predictable force by means of a spring 454 received in the recess 466. In
In another embodiment (not shown), the spring 454 comprises a compressed elastomer, which may take the form of a column that fills some or all of the diameter of the recess 466. The elastomer may comprise a biocompatible polymeric material, for example. In such an embodiment, the elastomer may be electrically conductive, e.g., by filling a polymeric material with a suitable quantity of a conductive metal powder or the like. In another embodiment, one or more wires may be embedded in the elastomeric material to conduct an electrical signal across the elastomer to the shaft 452.
In the illustrated embodiment and the alternative embodiment wherein the spring 454 comprises an elastomer, the head 460 may be formed of a dielectric material, helping electrically insulate the skull 10 from the shaft 452. In an alternative embodiment, the head 460 may be formed of an electrically conductive material. Even though the other structural elements of the electrode 450 may remain largely the same, this would avoid the necessity of having the lead 468 extend through the head 460; an electrically conducive ring 122 or the like instead may be employed in a manner analogous to that shown in
The contact surface 481 of the shaft 480 is pushed against the surface of the dura mater 20 with a predictable force by means of a spring 486. The spring 486 may be substantially the same as the spring 454 shown in
In
The electrode 475 of
To implant the electrode 500 in the skull 10, the shaft 510 may be advanced into a bore in the skull until the contact surface 515 exerts the desired contact force against the dura mater 20. Once the shaft 510 is in the desired position, the compressive force F on the collar 540 may be released, allowing the collar 540 to expand outwardly into compressive engagement with the lumen of the bore in the skull 10. This will help hold the electrode 500 in place with respect to the skull without requiring permanent anchoring of the shaft 510 to the skull 10.
The shaft 510 may be electrically coupled to a pulse system (not shown) by a lead 520. The lead 520 may include a cap 522 having an electrically conductive inner surface 524 coupled to a body 526 of the lead. The lead 520 may be analogous to the lead 160 shown in
In one embodiment, the collar 540 comprises a dielectric material. This will help electrically insulate the skull 10 from the shaft 510. In another embodiment, the collar 540 is electrically conductive and the lead 520 may be electrically coupled to the shaft 510 via the collar 540.
In the embodiment shown in
In use, the conductive member 570 may be slid freely through a pilot hole 11 formed through the skull to position the tip 574 at the target site 28 in a known manner. The pilot hole 11 may be larger than the conductive member 570 or be tapped to receive the threads of the shaft 560. With the conductive member 570 in place, the shaft 560 may be threaded into the pilot hole 11, crimping the conductive member 570 against an interior of the pilot hole 11. This will fix the conductive member 570 in place. If so desired, a proximal length 572 of the conductive member 570 may extend outwardly of the skull and be held in place by the head 562. The threads of the threaded shaft 560 may also cut through the dielectric sheath of the conductive member 570 as the shaft 560 is screwed into place, making electrical contact with the conductive wire therein.
The gimbal fitting 630 is adapted to allow an operator greater control over the placement of the electrically conductive tip 574 of the conductive member 570. In use, the tip 574 of the conductive member 570 will be threaded through an opening in the gimbal fitting 630. By pivoting the gimbal fitting 630 with respect to the threaded shaft 620 of the head 610, the angular orientation of the conductive member 570 with respect to the pilot hole 11 in the skull 10 can be accurately controlled. Once the operator determines that the conductive member 570 is at the appropriate angle, e.g., using a surgical navigation system such as that noted below, the operator may advance the conductive member 570 to position the conductive tip 574 at the target site 28. Once the tip 574 is in position, the cap 162 of a lead 160 may be press-fitted on the head 610 of the electrode 600. This will crimp the proximal length 572 of the conductive member 570 between the head 610 and the conductive inner surface 163 of the cap 162, providing an effective electrical connection between the conductive member 570 and the body 164 of the lead 160.
C. Systems Employing Intracranial Electrodes
The pulse system 1050 may be implanted in the body of the patient P at a location remote from the array 1010 of electrodes 100. In the embodiment shown in
In one embodiment, the controller 1060 includes a processor, a memory, and a programmable computer medium. The controller 1060, for example, can be a computer, and the programmable computer medium can be software loaded into the memory of the computer and/or hardware that performs the requisite control functions. In an alternative embodiment suggested by dashed lines in
The controller 1060 is operatively coupled to and provides control signals to the pulse generator 1065, which may include a plurality of channels that send appropriate electrical pulses to the pulse transmitter 1070. The pulse generator 1065 may have N channels, with at least one channel associated with each of N electrodes 100 in the array 1010. The pulse generator 1065 sends appropriate electrical pulses to the pulse transmitter 1070, which is coupled to a plurality of electrodes 1080. In one embodiment, each of these electrodes is adapted to be physically connected to the body 124 of a separate lead, allowing each electrode 1080 to electrically communicate with a single electrode 100 in the array 1010 on a dedicated channel of the pulse generator 1065. Suitable components for the power supply 1055, the integrated controller 1060, the pulse generator 1065, and the pulse transmitter 1070 are known to persons skilled in the art of implantable medical devices.
As shown in
The electrodes 100 of these arrays 1010 may be provided with electrical signals in a variety of different manners. In some circumstances, one electrode 100 or a subset of the electrodes 100 may have one electrical potential and a different electrode 100 or subset of the electrodes 100 (or, in some embodiments, the housing 1052 of the pulse system 1050) may have a different electrical potential. U.S. patent application Ser. No. 09/978,134, entitled “Systems and Methods for Automatically Optimizing Stimulus Parameters and Electrode Configurations for Neuro-Stimulators” and filed Oct. 15, 2001 (the entirety of which is incorporated herein by reference), suggests ways for optimizing the control of the electrical pulses delivered to the electrodes 100 in an array 1010. The methods and apparatus disclosed therein may be used to automatically determine the configuration of therapy electrodes and/or the parameters for the stimulus to treat or otherwise effectuate a change in neural function of a patient.
The preceding discussion focuses on use of intracranial electrodes (e.g., electrodes 100, 150, 200, 250, 300, 350, 400, 450, 475, 500, 550, or 600) in neurostimulation systems. In an alternative application, the intracranial electrodes may be used to monitor electrical potentials in electroencephalography. A suitable electroencephalograph may incorporate a system similar to the neurostimulation system 1000 shown in
D. Methods
As noted above, other embodiments of the invention provide methods of implanting an intracranial electrode and/or methods of installing a neurostimulation system including an implantable intracranial electrode. In the following discussion, reference is made to the particular intracranial electrode 100 illustrated in
As noted above, implanting conventional cortical electrodes typically requires a full craniotomy under general anesthesia to remove a relatively large (e.g., thumbnail-sized or larger) window in the skull. Craniotomies are performed under a general anesthetic and subject the patient to increased chances of infection.
In accordance with one embodiment of the present invention, however, the diameter of the electrode shaft 110 is sufficiently small to permit implantation under local anesthetic without requiring a craniotomy. In this embodiment, a relatively small (e.g., 4 mm or smaller) pilot hole may be formed through at least part of the thickness of the patient's skull adjacent a selected stimulation or monitoring site of the brain. When implanting the electrode 100 of
The location of the pilot hole (and, ultimately the electrode 100 received therein) can be selected in a variety of fashions. U.S. Patent Application Publication No. U.S. 2002/0087201 and U.S. application Ser. No. 09/978,134 (both of which are incorporated hereinabove), for example, suggest approaches for selecting an appropriate stimulation site. When the desired site has been identified, the physician can bore the pilot hole to guide the contact surface 115 of the electrode 100 to that site. In one embodiment, the physician may use anatomical landmarks, e.g., cranial landmarks such as the bregma or the sagittal suture, to guide placement and orientation of the pilot hole. In another embodiment, a surgical navigation system may be employed to inform the physician during the procedure. Briefly, such systems may employ real-time imaging and/or proximity detection to guide a physician in placing the pilot hole and in placing the electrode 100 in the pilot hole. In some systems, fiducials are positioned on the patient's scalp or skull prior to imaging and those fiducials are used as reference points in subsequent implantation. In other systems, real-time MRI or the like may be employed instead of or in conjunction with such fiducials. A number of suitable navigation systems are commercially available, such as the STEALTHSTATION TREON TGS sold by Medtronic Surgical Navigation Technologies of Louisville, Colo., U.S.
Once the pilot hole is formed, the threaded electrode 100 may be advanced along the pilot hole until the contact surface 115 electrically contacts a desired portion of the patient's brain. If the electrode 100 is intended to be positioned epidurally, this may comprise relatively atraumatically contacting the dura mater 20; if the electrode is to contact a site on the cerebral cortex, the electrode will be advanced to extend through the dura mater. The electrodes 100 may also be implanted to a selected depth within the cerebral cortex or at a deeper location in the brain.
In one embodiment, the length of the electrode 100 is selected (or adjusted for electrode 300, for example) to achieve the desired level of contact and the electrode will be advanced until a known relationship with the skull is achieved, e.g., when the head 102 compresses the contact ring 122 of the lead 120 against the exterior of the skull 10. In another embodiment, the thickness of the skull 10 need not be known to any significant accuracy before the electrode 100 is implanted. Instead, the electrode 100 may be connected, e.g., via the lead 120, to an impedance monitor and the impedance may be monitored as the electrode 100 is being implanted. It is anticipated that the measured impedance will change when the electrode 100 contacts the dura mater 20. Once this contact is detected, the physician may advance the electrode a small, fixed distance to ensure reliable electrical contact over time.
As noted above, the electrode 100 may be coupled to a lead 120. The timing of this coupling may vary with the nature of the coupling. For a lead 120 employing a contact ring 122 or the like positioned below the head 102, the lead may be coupled to the electrode before the electrode is introduced into the skull. In other embodiments, the lead (e.g., lead 160 of
Once the electrode is in place, an electrical stimulus may be delivered from a pulse system 1050 to the patient's brain via the lead 120 and the electrode 100. In certain embodiments of the invention discussed previously, a plurality of electrodes 100 may be implanted in an array (e.g., array 1010, 1010a, 1010b, or 1010c) in the patient's skull and each of the electrodes 100 may be coupled to the pulse system 1050 by an electrically separate lead 120. The precise nature of the stimulus delivered via the electrode(s) 100 can be varied as desired to diagnose or treat any particular condition. The type and frequency of stimulus may be selected as outlined in U.S. patent application Publication No. U.S. 2002/0087201, for example, and also may be optimized as taught in U.S. application Ser. No. 09/978,134.
Unless the context clearly requires otherwise, throughout the description and the claims, the words “comprise,” “comprising,” and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense, that is to say, in a sense of “including, but not limited to.” Words using the singular or plural number also include the plural or singular number, respectively. When the claims use the word “or” in reference to a list of two or more items, that word covers all of the following interpretations of the word: any of the items in the list, all of the items in the list, and any combination of the items in the list.
The above-detailed descriptions of embodiments of the invention are not intended to be exhaustive or to limit the invention to the precise form disclosed above. While specific embodiments of, and examples for, the invention are described above for illustrative purposes, various equivalent modifications are possible within the scope of the invention, as those skilled in the relevant art will recognize. For example, whereas steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein can be combined to provide further embodiments.
In general, the terms used in the following claims should not be construed to limit the invention to the specific embodiments disclosed in the specification, unless the above-detailed description explicitly defines such terms. While certain aspects of the invention are presented below in certain claim forms, the inventors contemplate the various aspects of the invention in any number of claim forms. Accordingly, the inventors reserve the right to add additional claims after filing the application to pursue such additional claim forms for other aspects of the invention.
This application claims priority from Provisional Application Ser. No. 60/429,481, filed Nov. 27, 2002.
Number | Name | Date | Kind |
---|---|---|---|
2716226 | Jonas | Aug 1955 | A |
2721316 | Shaw | Oct 1955 | A |
3628193 | Collins | Dec 1971 | A |
3650276 | Burghele et al. | Mar 1972 | A |
3918461 | Cooper | Nov 1975 | A |
4030509 | Heilman et al. | Jun 1977 | A |
4125116 | Fischell | Nov 1978 | A |
4140133 | Kastrubin et al. | Feb 1979 | A |
4214804 | Little | Jul 1980 | A |
4245645 | Picard et al. | Jan 1981 | A |
4308868 | Jhabvala | Jan 1982 | A |
4328813 | Ray | May 1982 | A |
4340038 | McKean | Jul 1982 | A |
4431000 | Butler et al. | Feb 1984 | A |
4474186 | Ledley et al. | Oct 1984 | A |
4487210 | Knudsen et al. | Dec 1984 | A |
4542752 | DeHaan et al. | Sep 1985 | A |
4590946 | Loeb | May 1986 | A |
4607639 | Tanagho et al. | Aug 1986 | A |
4646744 | Capel | Mar 1987 | A |
4702254 | Zabara | Oct 1987 | A |
4844075 | Liss et al. | Jul 1989 | A |
4865048 | Eckerson | Sep 1989 | A |
4936306 | Doty | Jun 1990 | A |
4969468 | Byers et al. | Nov 1990 | A |
5002053 | Garcia-Rill et al. | Mar 1991 | A |
5024226 | Tan | Jun 1991 | A |
5031618 | Mullett | Jul 1991 | A |
5054906 | Lyons, Jr. | Oct 1991 | A |
5063932 | Dahl et al. | Nov 1991 | A |
5092835 | Schurig et al. | Mar 1992 | A |
5121754 | Mullett | Jun 1992 | A |
5143089 | Alt | Sep 1992 | A |
5169384 | Bosniak et al. | Dec 1992 | A |
5184620 | Cudahy et al. | Feb 1993 | A |
5193540 | Schulman et al. | Mar 1993 | A |
5215086 | Terry, Jr. et al. | Jun 1993 | A |
5215088 | Normann et al. | Jun 1993 | A |
5224491 | Mehra | Jul 1993 | A |
5255678 | Deslauriers et al. | Oct 1993 | A |
5263967 | Lyons, III et al. | Nov 1993 | A |
5271417 | Swanson et al. | Dec 1993 | A |
5282468 | Klepinski | Feb 1994 | A |
5292252 | Nickerson et al. | Mar 1994 | A |
5299569 | Wernicke et al. | Apr 1994 | A |
5303705 | Nenov | Apr 1994 | A |
5304206 | Baker, Jr. et al. | Apr 1994 | A |
5314458 | Najafi et al. | May 1994 | A |
5358513 | Powell, III et al. | Oct 1994 | A |
5370672 | Fowler et al. | Dec 1994 | A |
5405375 | Ayers et al. | Apr 1995 | A |
5406957 | Tansey | Apr 1995 | A |
5411540 | Edell et al. | May 1995 | A |
5417719 | Hull et al. | May 1995 | A |
5423864 | Ljungstroem | Jun 1995 | A |
5464446 | Dreessen et al. | Nov 1995 | A |
5520190 | Benedict et al. | May 1996 | A |
5522864 | Wallace et al. | Jun 1996 | A |
5537512 | Hsia et al. | Jul 1996 | A |
5540734 | Zabara | Jul 1996 | A |
5540736 | Haimovich et al. | Jul 1996 | A |
5549655 | Erickson | Aug 1996 | A |
5562708 | Combs et al. | Oct 1996 | A |
5575813 | Edell et al. | Nov 1996 | A |
5591216 | Testerman et al. | Jan 1997 | A |
5593432 | Crowther et al. | Jan 1997 | A |
5601611 | Fayram et al. | Feb 1997 | A |
5611350 | John | Mar 1997 | A |
5618531 | Cherksey | Apr 1997 | A |
5628317 | Starkebaum et al. | May 1997 | A |
5674251 | Combs et al. | Oct 1997 | A |
5676655 | McCulloch et al. | Oct 1997 | A |
5683422 | Rise | Nov 1997 | A |
5702429 | King | Dec 1997 | A |
5707334 | Young | Jan 1998 | A |
5711316 | Elsberry et al. | Jan 1998 | A |
5713922 | King | Feb 1998 | A |
5713923 | Ward et al. | Feb 1998 | A |
5716377 | Rise et al. | Feb 1998 | A |
5722401 | Pietroski et al. | Mar 1998 | A |
5725377 | Lemler et al. | Mar 1998 | A |
5735814 | Elsberry et al. | Apr 1998 | A |
5738521 | Dugot | Apr 1998 | A |
5750376 | Weiss et al. | May 1998 | A |
5752979 | Benabid | May 1998 | A |
5769778 | Abrams et al. | Jun 1998 | A |
5772591 | Cram | Jun 1998 | A |
5782798 | Rise | Jul 1998 | A |
5782873 | Collins | Jul 1998 | A |
5792186 | Rise | Aug 1998 | A |
5797970 | Pouvreau | Aug 1998 | A |
5814014 | Elsberry et al. | Sep 1998 | A |
5814092 | King | Sep 1998 | A |
5824021 | Rise | Oct 1998 | A |
5824030 | Yang et al. | Oct 1998 | A |
5832932 | Elsberry et al. | Nov 1998 | A |
5833709 | Rise et al. | Nov 1998 | A |
5843148 | Gijsbers et al. | Dec 1998 | A |
5843150 | Dreessen et al. | Dec 1998 | A |
5865842 | Knuth et al. | Feb 1999 | A |
5871517 | Abrams et al. | Feb 1999 | A |
5885976 | Sandyk | Mar 1999 | A |
5886769 | Zolten | Mar 1999 | A |
5893883 | Torgerson et al. | Apr 1999 | A |
5904916 | Hirsch | May 1999 | A |
5913882 | King | Jun 1999 | A |
5916171 | Mayevsky | Jun 1999 | A |
5925070 | King et al. | Jul 1999 | A |
5938688 | Schiff | Aug 1999 | A |
5938689 | Fischell et al. | Aug 1999 | A |
5941906 | Barreras, Sr. et al. | Aug 1999 | A |
5964794 | Bolz et al. | Oct 1999 | A |
5975085 | Rise | Nov 1999 | A |
5978702 | Ward et al. | Nov 1999 | A |
5983140 | Smith et al. | Nov 1999 | A |
6006124 | Fischell et al. | Dec 1999 | A |
6011996 | Gielen et al. | Jan 2000 | A |
6016449 | Fischell et al. | Jan 2000 | A |
6018682 | Rise | Jan 2000 | A |
6021352 | Christopherson et al. | Feb 2000 | A |
6026326 | Bardy | Feb 2000 | A |
6034295 | Rehberg et al. | Mar 2000 | A |
6035236 | Jarding et al. | Mar 2000 | A |
6040180 | Johe | Mar 2000 | A |
6042579 | Elsberry et al. | Mar 2000 | A |
6052624 | Mann | Apr 2000 | A |
6055456 | Gerber | Apr 2000 | A |
6057846 | Sever, Jr. | May 2000 | A |
6057847 | Jenkins | May 2000 | A |
6058331 | King | May 2000 | A |
6060048 | Cherksey | May 2000 | A |
6061593 | Fischell et al. | May 2000 | A |
6066163 | John | May 2000 | A |
6095148 | Shastri et al. | Aug 2000 | A |
6104956 | Naritoku et al. | Aug 2000 | A |
6104960 | Duysens et al. | Aug 2000 | A |
6122548 | Starkebaum et al. | Sep 2000 | A |
6126657 | Edwards et al. | Oct 2000 | A |
6128537 | Rise | Oct 2000 | A |
6128538 | Fischell et al. | Oct 2000 | A |
6134474 | Fischell | Oct 2000 | A |
6152143 | Edwards | Nov 2000 | A |
6161044 | Silverstone | Dec 2000 | A |
6161045 | Fischell et al. | Dec 2000 | A |
6176242 | Rise | Jan 2001 | B1 |
6190893 | Shastri et al. | Feb 2001 | B1 |
6198958 | Ives et al. | Mar 2001 | B1 |
6205360 | Carter et al. | Mar 2001 | B1 |
6210417 | Baudino et al. | Apr 2001 | B1 |
6221908 | Kilgard et al. | Apr 2001 | B1 |
6230049 | Fischell et al. | May 2001 | B1 |
6236892 | Feler | May 2001 | B1 |
6246912 | Sluijter et al. | Jun 2001 | B1 |
6280462 | Hauser et al. | Aug 2001 | B1 |
6301493 | Marro et al. | Oct 2001 | B1 |
6319241 | King et al. | Nov 2001 | B1 |
6339725 | Naritoku et al. | Jan 2002 | B1 |
6353754 | Fischell | Mar 2002 | B1 |
6354299 | Fischell | Mar 2002 | B1 |
6356792 | Errico et al. | Mar 2002 | B1 |
6360122 | Fischell | Mar 2002 | B1 |
6366813 | DiLorenzo | Apr 2002 | B1 |
6375666 | Mische | Apr 2002 | B1 |
6405079 | Ansarinia | Jun 2002 | B1 |
6418344 | Rezai et al. | Jul 2002 | B1 |
6427086 | Fischell | Jul 2002 | B1 |
6456886 | Howard, III et al. | Sep 2002 | B1 |
6459936 | Fischell | Oct 2002 | B2 |
6463328 | John | Oct 2002 | B1 |
6464356 | Sabel | Oct 2002 | B1 |
6466822 | Pless | Oct 2002 | B1 |
6473639 | Fischell | Oct 2002 | B1 |
6480743 | Kirkpatrick | Nov 2002 | B1 |
6484059 | Gielen | Nov 2002 | B2 |
6487450 | Chen | Nov 2002 | B1 |
6499488 | Hunter et al. | Dec 2002 | B1 |
6505075 | Weiner | Jan 2003 | B1 |
6507755 | Gozani et al. | Jan 2003 | B1 |
6529774 | Greene | Mar 2003 | B1 |
6539263 | Schiff et al. | Mar 2003 | B1 |
6556868 | Naritoku et al. | Apr 2003 | B2 |
6569654 | Shastri et al. | May 2003 | B2 |
6591138 | Fischell et al. | Jul 2003 | B1 |
6597954 | Pless et al. | Jul 2003 | B1 |
6615065 | Barrett et al. | Sep 2003 | B1 |
6622048 | Mann | Sep 2003 | B1 |
6633780 | Berger | Oct 2003 | B1 |
6647296 | Fischell et al. | Nov 2003 | B2 |
6658299 | Dobelle | Dec 2003 | B1 |
6665562 | Gluckman et al. | Dec 2003 | B2 |
6684105 | Cohen et al. | Jan 2004 | B2 |
6687525 | Llinas | Feb 2004 | B2 |
6690974 | Archer et al. | Feb 2004 | B2 |
6708064 | Rezai | Mar 2004 | B2 |
6725094 | Saberski | Apr 2004 | B2 |
6764498 | Mische | Jul 2004 | B2 |
6782292 | Whitehurst | Aug 2004 | B2 |
6788975 | Whitehurst et al. | Sep 2004 | B1 |
6795737 | Gielen et al. | Sep 2004 | B2 |
6810286 | Donovan et al. | Oct 2004 | B2 |
6839594 | Cohen et al. | Jan 2005 | B2 |
6873872 | Gluckman et al. | Mar 2005 | B2 |
6892097 | Holsheimer | May 2005 | B2 |
6895280 | Meadows et al. | May 2005 | B2 |
6907296 | Doan et al. | Jun 2005 | B1 |
6934580 | Osorio et al. | Aug 2005 | B1 |
6944497 | Stypulkowski | Sep 2005 | B2 |
6944501 | Pless | Sep 2005 | B1 |
6959215 | Gliner et al. | Oct 2005 | B2 |
6990377 | Gliner et al. | Jan 2006 | B2 |
7006859 | Osorio et al. | Feb 2006 | B1 |
7010351 | Firlik et al. | Mar 2006 | B2 |
7024247 | Gliner et al. | Apr 2006 | B2 |
7110820 | Tcheng et al. | Sep 2006 | B2 |
20020077670 | Archer | Jun 2002 | A1 |
20020087201 | Firlik et al. | Jul 2002 | A1 |
20020091419 | Firlik | Jul 2002 | A1 |
20020099412 | Fischell | Jul 2002 | A1 |
20020169485 | Pless | Nov 2002 | A1 |
20030074032 | Gliner | Apr 2003 | A1 |
20030078633 | Firlik et al. | Apr 2003 | A1 |
20030088274 | Gliner et al. | May 2003 | A1 |
20030097161 | Firlik et al. | May 2003 | A1 |
20030114886 | Gluckman et al. | Jun 2003 | A1 |
20030125772 | Olson et al. | Jul 2003 | A1 |
20030125786 | Gliner et al. | Jul 2003 | A1 |
20030130706 | Sheffield et al. | Jul 2003 | A1 |
20030149457 | Tcheng et al. | Aug 2003 | A1 |
20030176901 | May | Sep 2003 | A1 |
20030187490 | Gliner | Oct 2003 | A1 |
20030187491 | Greenberg et al. | Oct 2003 | A1 |
20040073270 | Firlik et al. | Apr 2004 | A1 |
20040082847 | McDermott | Apr 2004 | A1 |
20040088024 | Firlik et al. | May 2004 | A1 |
20040092809 | Decharms | May 2004 | A1 |
20040102828 | Lowry et al. | May 2004 | A1 |
20040111127 | Gliner et al. | Jun 2004 | A1 |
20040131998 | Marom et al. | Jul 2004 | A1 |
20040138550 | Hartlep et al. | Jul 2004 | A1 |
20040158298 | Gliner | Aug 2004 | A1 |
20040176831 | Gliner et al. | Sep 2004 | A1 |
20040181263 | Balzer et al. | Sep 2004 | A1 |
20040215287 | Swoyer et al. | Oct 2004 | A1 |
20040236388 | Gielen et al. | Nov 2004 | A1 |
20040243205 | Keravel et al. | Dec 2004 | A1 |
20040249422 | Gliner et al. | Dec 2004 | A1 |
20050004620 | Singhal et al. | Jan 2005 | A1 |
20050015129 | Mische | Jan 2005 | A1 |
20050021104 | DiLorenzo | Jan 2005 | A1 |
20050021105 | Firlik et al. | Jan 2005 | A1 |
20050021106 | Firlik et al. | Jan 2005 | A1 |
20050021107 | Firlik et al. | Jan 2005 | A1 |
20050021118 | Genau et al. | Jan 2005 | A1 |
20050033378 | Sheffield et al. | Feb 2005 | A1 |
20050070971 | Fowler et al. | Mar 2005 | A1 |
20050075679 | Gliner et al. | Apr 2005 | A1 |
20050075680 | Lowry et al. | Apr 2005 | A1 |
20050096701 | Donovan et al. | May 2005 | A1 |
20050113882 | Cameron et al. | May 2005 | A1 |
20050119712 | Shafer | Jun 2005 | A1 |
20050154425 | Boveja et al. | Jul 2005 | A1 |
20050154426 | Boveja et al. | Jul 2005 | A1 |
20050182453 | Whitehurst | Aug 2005 | A1 |
20060015153 | Gliner et al. | Jan 2006 | A1 |
20060106430 | Fowler et al. | May 2006 | A1 |
20060106431 | Wyler et al. | May 2006 | A1 |
20060129205 | Boveja et al. | Jun 2006 | A1 |
20060173522 | Osorio | Aug 2006 | A1 |
20060217782 | Boveja et al. | Sep 2006 | A1 |
20060241717 | Whitehurst et al. | Oct 2006 | A1 |
Number | Date | Country |
---|---|---|
19750043 | May 1999 | DE |
0214527 | Mar 1987 | EP |
0319844 | Jun 1989 | EP |
0 998 958 | Oct 2000 | EP |
1 145 736 | Oct 2001 | EP |
1180056 | Nov 2003 | EP |
WO 8607543 | Dec 1986 | WO |
WO 9729708 | Aug 1987 | WO |
WO-8707511 | Dec 1987 | WO |
WO-9407564 | Apr 1994 | WO |
WO-9521591 | Aug 1995 | WO |
WO-9806342 | Feb 1998 | WO |
WO 9934754 | Jul 1999 | WO |
WO 0013743 | Mar 2000 | WO |
WO 0100097 | Jan 2001 | WO |
WO-0197906 | Dec 2001 | WO |
WO-0209811 | Feb 2002 | WO |
WO-0236003 | May 2002 | WO |
WO-0238031 | May 2002 | WO |
WO-0238217 | May 2002 | WO |
WO-03082402 | Mar 2003 | WO |
WO-03043690 | May 2003 | WO |
Number | Date | Country | |
---|---|---|---|
20040102828 A1 | May 2004 | US |
Number | Date | Country | |
---|---|---|---|
60429481 | Nov 2002 | US |